Results from a long-term open-label extension study of adjunctive buprenorphine/samidorphan combination in patients with major depressive disorder

Neuropsychopharmacology · Elsevier

Аннотация

Publication date: December 2019 Source: Neuropsychopharmacology, Volume 44, Issue 13 Author(s): Michael E. Thase, Arielle D. Stanford, Asli Memisoglu, William Martin, Amy Claxton, J. Alexander Bodkin, Madhukar H. Trivedi, Maurizio Fava, Miao Yu, Sanjeev Pathak

Читать у издателя →

Похожие статьи